Enhanced dehydroepiandrosterone levels are positively correlated with N3 sleep stage in long-term mindfulness meditation practitioners

Objectives Meditation practices positively influence the neural, hormonal and autonomic systems. We have demonstrated that long-term practice of mindfulness meditation increases N3 and rapid eye movement (REM) sleep stages and bring efficient autonomic modulation during sleep. In the present study, the probable humoral correlation that could bring about these changes is evaluated.

Material and Methods Long-term Vipassana meditators (n=41) and controls (n=24) (males, 30-60 years of age) underwent a two-day consecutive whole night polysomnography recording. During the second day, with exposure to 100Lux brightness, blood was sampled from the antecubital vein between 8-9 PM and in subsequent early morning. Sleep stage was scored as per American Society of Sleep Medicine (ASSM) guidelines for the second-day recording. Sleep-related hormones were estimated - melatonin by radioimmunoassay; dehydroepiandrosterone (DHEA), cortisol, growth hormone (GH) and prolactin with enzyme-linked immunosorbent assay (ELISA); DHEA/cortisol ratio was calculated. Percentage of sleep stages and hormonal levels were compared between both groups using independent ‘t’ test and Pearson’s correlation was estimated between sleep stages and hormonal levels.

Results Meditators showed increased N3, REM sleep stages. Though evening cortisol was comparable between the two groups; early morning cortisol, diurnal DHEA and melatonin were significantly higher in meditators. Diurnal DHEA correlated significantly with the N3 sleep stage in meditators.

Discussion Higher diurnal DHEA despite variations in corresponding cortisol in meditators demonstrates that long-term Vipassana meditation practice modulates the hypothalamicpituitary-adrenal (HPA) axis and thereby influences sleep. Thus, the study provides evidence to explore the mechanism most likely involved with mindfulness meditation intervention in insomnia.

Mindfulness - Sleep - Dehydroepiandrosterone - Hydrocortisone - Melatonin - Sleep, Slow-Wave

Data

The data will be made available on specific requests to the corresponding author.

Funding source

The study was funded by CCRYN (Central Council for Research in Yoga and Naturopathy), Dept. of AYUSH, Ministry of Health and Family welfare Govt. of India, New Delhi (project no. 12-2/Res/CCRYN/2003-2004).

Publication History

Received: 17 April 2021

Accepted: 01 November 2021

Article published online:
01 December 2023

• REFERENCES

• 1 Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V, et al. The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep. 2007 Jun;30(6):737-42.
• 2 Rusch HL, Rosario M, Levison LM, Olivera A, Livingston WS, Wu T, et al. The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Ann N Y Acad Sci. 2019 Jun;1445(1):5-16.
• 3 Ong JC, Ulmer CS, Manber R. Improving sleep with mindfulness and acceptance: a metacognitive model of insomnia. Behav Res Ther. 2012 Nov;50(11):651-60.
• 4 Greeson JM, Zarrin H, Smoski MJ, Brantley JG, Lynch TR, Webber DM, et al. Mindfulness meditation targets transdiagnostic symptoms implicated in stress-related disorders: understanding relationships between changes in mindfulness, sleep quality, and physical symptoms. Evid Based Complement Alternat Med. 2018;2018:4505191.
• 5 Khalsa SBS. Treatment of chronic insomnia with yoga: a preliminary study with sleep-wake diaries. Appl Psychophysiol Biofeedback. 2004 Dec;29(4):269-78.
• 6 Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014 Sep;37(9):1553-63.
• 7 Hubbling A, Reilly-Spong M, Kreitzer MJ, Gross CR. How mindfulness changed my sleep: focus groups with chronic insomnia patients. BMC Complement Altern Med. 2014 Feb;14(1):50.
• 8 Irwin MR, Olmstead R, Motivala SJ. Improving sleep quality in older adults with moderate sleep complaints: a randomized controlled trial of Tai Chi Chih. Sleep. 2008 Jul;31(7):1001-8.
• 9 Mason LI, Alexander CN, Travis FT, Marsh G, Orme-Johnson D, Gackenbach J, et al. Electrophysiological correlates of higher states of consciousness during sleep in long-term: Practitioners of the transcendental meditation program. Sleep. 1997 Feb;20(2):102-10.
• 10 Sulekha S, Thennarasu K, Vedamurthachar A, Raju TR, Kutty BM. Evaluation of sleep architecture in practitioners of Sudarshan Kriya yoga and Vipassana meditation. Sleep Biol Rhythms. 2006;4(3):207-14.
• 11 Pattanashetty R, Sathiamma S, Talakkad S, Nityananda P, Trichur R, Kutty BM. Practitioners of Vipassana meditation exhibit enhanced slow wave sleep and REM sleep states across different age groups. Sleep Biol Rhythms. 2010;8(1):34-41.
• 12 Maruthai N, Nagendra RP, Sasidharan A, Srikumar S, Datta K, Uchida S, et al. Senior Vipassana meditation practitioners exhibit distinct REM sleep organization from that of novice meditators and healthy controls. Int Rev Psychiatry. 2016 Jun;28(3):279-87.
• 13 Mourtazaev MS, Kemp B, Zwinderman AH, Kamphuisen HA. Age and gender affect different characteristics of slow waves in the sleep EEG. Sleep. 1995 Sep;18(7):557-64.
• 14 Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ. Longterm meditators self-induce highamplitude gamma synchrony during mental practice. Proc Natl Acad Sci. 2004 Nov;101(46):16369-73.
• 15 Dentico D, Ferrarelli F, Riedner BA, Smith R, Zennig C, Lutz A, et al. Short meditation trainings enhance non-REM sleep low-frequency oscillations. PLoS One. 2016 Feb;11(2):e0148961.
• 16 Nagendra R, Sulekha S, Sasidharan A, Sathyaprabha T, Pradhan N, Raju T, et al. Vipassana meditation practices enhance the parasympathetic activity during sleep: A case-control study of heart rate variability across sleep cycles. Int J Complement Alt Med. 2017;5(2):14-12.
• 17 Jevning R, Wilson AF, Davidson JM. Adrenocortical activity during meditation. Hormon Behav. 1978 Feb;10(1):54-60.
• 18 Infante JR, Torres-Avisbal M, Pinel P, Vallejo JA, Peran F, Gonzalez F, et al. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav. 2001 Jan;72(1-2):141-6.
• 19 Glaser JL, Brind JL, Vogelman JH, Eisner MJ, Dillbeck MC, Wallace RK, et al. Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med. 1992 Aug;15(4):327-41.
• 20 Jevning R, Wallace RK, Beidebach M. The physiology of meditation: a review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev. 1992;16(3):415-24.
• 21 Werner OR, Wallace RK, Charles B, Janssen G, Stryker T, Chalmers RA. Long-term endocrinologic changes in subjects practicing the Transcendental Meditation and TM-Sidhi program. Psychosom Med. 1986;48(1-2):59-66.
• 22 MacLean CR, Waltson KG, Wennenberg SR, Levitsky DK, Mandarino JV, Waziri R, et al. Altered responses of cortisol, GH, TSH and testosterone to acute stress after four months’ practice of transcendental meditation (TM). Ann N Y Acad Sci. 1995 Nov;746:381-4.
• 23 Massion AO, Teas J, Hebert JR, Wertheimer M, Kabat-Zinn J. Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. Med Hypotheses. 1995 Jan;44(1):39-46.
• 24 Tooley GA, Armstrong SM, Norman TR, Sali A. Acute increases in night-time plasma melatonin levels following a period of meditation. Biol Psychol. 2000 May;53(1):69-78.
• 25 Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004 May;29(4):448-74.
• 26 Krueger JM, Fang J, Hansen MK, Zhang J, Obal Junior F. Humoral regulation of sleep. News Physiol Sci. 1998 Aug;13(4):189-94.
• 27 Liou CH, Hsieh CW, Hsieh CH, Chen DY, Wang CH, Chen JH, et al. Detection of nighttime melatonin level in Chinese Original Quiet Sitting. J Form Med Assoc. 2010 Oct;109(10):694-701.
• 28 Harinath K, Malhotra AS, Pal K, Prasad R, Kumar R, Kain TC, et al. Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med. 2004 Apr;10(2):261-8.
• 29 Bottaccioli F, Carosella A, Cardone R, Mambelli M, Cemin M, D’Errico MM, et al. Brief training of psychoneuroendocrinoimmunology-based meditation (PNEIMED) reduces stress symptom ratings and improves control on salivary cortisol secretion under basal and stimulated conditions. Explore (NY). 2014 May/Jun;10(3):170-9.
• 30 Turakitwanakan W, Mekseepralard C, Busarakumtragul P. Effects of mindfulness meditation on serum cortisol of medical students. J Med Assoc Thai. 2013 Jan;96(Suppl 1):S90-S5.
• 31 Solberg EE, Holen A, Ekeberg O, Osterud B, Halvorsen R, Sandvik L. The effects of long meditation on plasma melatonin and blood serotonin. Med Sci Monit. 2004 Mar;10(3):CR96-CR101.
• 32 Fernandes CA, Nóbrega YK, Tosta CE. Pranic meditation affects phagocyte functions and hormonal levels of recent practitioners. J Altern Complement Med. 2012 Aug;18(8):761-8.
• 33 Jacobs TL, Shaver PR, Epel ES, Zanesco AP, Aichele SR, Bridwell DA, et al. Self-reported mindfulness and cortisol during a Shamatha meditation retreat. Health Psychol. 2013 Oct;32(10):1104-9.
• 34 Walton KG, Pugh ND, Gelderloos P, Macrae P. Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. J Altern Complement Med. 1995;1(3):263-83.
• 35 Cahn BR, Goodman MS, Peterson CT, Maturi R, Mills PJ. Yoga, meditation and mind-body health: increased BDNF, cortisol awakening response, and altered inflammatory marker expression after a 3month yoga and meditation retreat. Front Hum Neurosci. 2017 Jun;11:315.
• 36 Robb SW, Haslam A, Wirth MD, Gay JL, Middleton L, Healy M, et al. Relationship between Meditation and waking salivary cortisol secretion among long-term MBSR Instructors. Complement Med Res. 2019;26(2):101-9.
• 37 Klimes-Dougan B, Chong LS, Samikoglu A, Thai M, Amatya P, Cullen KR, et al. Transcendental meditation and hypothalamic-pituitaryadrenal axis functioning: a pilot, randomized controlled trial with young adults. Stress. 2020 Jan;23(1):105-15.
• 38 Delmonte MM. Biochemical indices associated with meditation practice: a literature review. Neurosci Biobehav Rev. 1985;9(4):557-61.
• 39 Nagendra RP, Maruthai N, Kutty BM. Meditation and its regulatory role on sleep. Front Neurol. 2012;3:54.
• 40 Silber MH, Ancoli-Israel S, Bonnet MH, Chokroverty S, Grigg- Damberger MM, Hirshkowitz M, et al. The visual scoring of sleep in adults. J Clin Sleep Med. 2007 Mar;3(2):121-31.
• 41 Almeida EA, Di Mascio P, Harumi T, Spence DW, Moscovitch A, Hardeland R, et al. Measurement of melatonin in body fluids: standards, protocols and procedures. Childs Nerv Syst. 2011 Jun;27(6):879-91.
• 42 Agarwal RP, Kumar A, Lewis JE. A pilot feasibility and acceptability study of yoga/meditation on the quality of life and markers of stress in persons living with HIV who also use crack cocaine. J Altern Complement Med. 2015 Mar;21(3):152-8.
• 43 Vera FM, Manzaneque JM, Maldonado EF, Carranque GA, Rodriguez FM, Blanca MJ, et al. Subjective sleep quality and hormonal modulation in long-term yoga practitioners. Biol Psychol. 2009 Jul;81(3):164-8.
• 44 Pascoe MC, Thompson DR, Ski CF. Meditation and endocrine health and wellbeing. Trends Endocrinol Metabol. 2020;31(7):469-77.
• 45 Jackowska M, Kumari M, Steptoe A. Sleep and biomarkers in the English Longitudinal Study of Ageing: associations with C-reactive protein, fibrinogen, dehydroepiandrosterone sulfate and hemoglobin. Psychoneuroendocrinology. 2013 Sep;38(9):1484-93.
• 46 Makino S, Fujiwara M, Handa H, Fujie T, Aoki Y, Hashimoto K, et al. Plasma dehydroepiandrosterone sulphate and insulin-like growth factor I levels in obstructive sleep apnoea syndrome. Clin Endocrinol (Oxf). 2012 Apr;76(4):593-601.
• 47 Goh VH, Tong TY. Sleep, sex steroid hormones, sexual activities, and aging in Asian men. J Androl. 2010 Mar/Apr;31(2):131-7.
• 48 Sousa G, Schlüeter B, Menke T, Trowitzsch E, Andler W, Reinehr T. Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome. J Sleep Res. 2011 Sep;20(3):472-8.
• 49 Schiffelholz T, Holsboer F, Lancel M. High doses of systemic DHEAsulfate do not affect sleep structure and elicit moderate changes in non- REM sleep EEG in rats. Physiol Behav. 2000 Jun;69(4-5):399-404.
• 50 Caufriez A, Leproult R, L’Hermite-Baleriaux M, Kerkhofs M, Copinschi G. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study. Clin Endocrinol (Oxf). 2013;79(5):716-24.
• 51 Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol. 1995 Jan;268(1):E107-13.
• 52 Goncharov NP, Katsiia GV, Nizhnik AN. Dehydroepiandrosterone and the cerebral functions. Vestn Ross Akad Med Nauk. 2006;(6):45-50.
• 53 Barrou Z, Charru P, Lidy C. Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriatr. 1997 May/Jun;24(3):233-41.
• 54 Yen SSC. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc Natl Acad Sci. 2001 Jul;98(15):8167-9.
• 55 Lindholm H, Ahlberg J, Sinisalo J, Hublin C, Hirvonen A, Partinen M, et al. Morning cortisol levels and perceived stress in irregular shift workers compared with regular daytime workers. Sleep Disord. 2012;2012:789274.
• 56 Duan H, Yuan Y, Zhang L, Qin S, Zhang K, Buchanan TW, et al. Chronic stress exposure decreases the cortisol awakening response in healthy young men. Stress. 2013 Nov;16(6):630-7.
• 57 Lovell B, Moss M, Wetherell MA. Perceived stress, common health complaints and diurnal patterns of cortisol secretion in young, otherwise healthy individuals. Horm Behav. 2011 Aug;60(3):301-5.
• 58 Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009 Apr;72(1):67-73.
• 59 Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010 Sep;35(1):97-103.
• 60 Guilliams TG, Edwards L. Chronic stress and the HPA axis. Standard. 2010;9(2):1-12.
• 61 Motzer SA, Hertig V. Stress, stress response, and health. Nurs Clin North Am. 2004 Mar;39(1):1-17.
• 62 Clow A, Law R, Evans P, Vallence AM, Hodyl NA, Goldsworthy MR, et al. Day differences in the cortisol awakening response predict day differences in synaptic plasticity in the brain. Stress. 2014 May;17(3):219-23.
• 63 Clow A, Hucklebridge F, Thorn L. The cortisol awakening response in context. Int Rev Neurobiol. 2010;93:153-75.
• 64 Kudielka B, Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology. 2003 Jan;28(1):35-47.
• 65 Williams E, Magid K, Steptoe A. The impact of time of waking and concurrent subjective stress on the cortisol response to awakening. Psychoneuroendocrinology. 2005 Feb;30(2):139-48.
• 66 Wust S, Wolf J, Hellhammer DH, Federenko I, Schommer N, Kirschbaum C. The cortisol awakening response-normal values and confounds. Noise Health. 2000;2(7):79-88.
• 67 Petrowski K, Schmalbach B, Stalder T. Morning and evening type: the cortisol awakening response in a sleep laboratory. Psychoneuroendocrinology. 2020 Feb;112:104519.
• 68 Matousek RH, Pruessner JC, Dobkin PL. Changes in the cortisol awakening response (CAR) following participation in mindfulnessbased stress reduction in women who completed treatment for breast cancer. Complement Ther Clin Pract. 2011 May;17(2):65-70.
• 69 Schmidt M, Naumann H, Weidler C, Schellenberg M, Anders S, Straub RH. Inflammation and sex hormone metabolism. Ann N Y Acad Sci. 2006 Jun;1069(1):236-46.
• 70 Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte S, et al. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol. 2001 Apr;144(4):319-29.
• 71 Chida Y, Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol. 2009 Mar;80(3):265-78.
• 72 Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: nature’s most versatile biological signal? FEBS J. 2006 Jul;273(13):2813-38.
• 73 Brzezinski A. Melatonin in humans. N Engl J Med. 1997 Jan;336(3):186-95.
• 74 Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben- Shushan A, et al. Effects of exogenous melatonin on sleep: a metaanalysis. Sleep Med Rev. 2005 Feb;9(1):41-50.
• 75 Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PloS One. 2013 May;8(5):e63773.
• 76 Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry. 2000 May;61(5):373-7.
• 77 Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res. 2007 Dec;16(4):372-80.
• 78 Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, et al. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int. 2000 Jan;17(1):71-6.
• 79 Mendelson WB. Efficacy of melatonin as a hypnotic agent. J Biol Rhythms. 1997 Dec;12(6):651-6.
• 80 Hughes RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleepmaintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep. 1998;21(1):52-68.
• 81 Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology (Berl). 1990;100(2):222-6.
• 82 Hughes R, Badia P, French J, Santiago L, Plenzler S. Melatonin induced changes in body temperature and daytime sleep. Sleep Res. 1994;23:496.
• 83 James SP, Mendelson WB, Sack DA, Rosenthal NE, Wehr TA. The effect of melatonin on normal sleep. Neuropsychopharmacology. 1987;1(1):41-4.
• 84 James SP, Sack DA, Rosenthal NE, Mendelson WB. Melatonin administration in insomnia. Neuropsychopharmacology. 1990 Feb;3(1):19-23.
• 85 Medeiros CAM, Bruin PFC, Lopes LA, Magalhães MC, Seabra ML, Bruin VMS. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease. J Neurol. 2007 Apr;254(4):459-64.
• 86 Dawson D, Rogers NL, Van Den Heuvel CJ, Kennaway DJ, Lushington K. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms. 1998 Dec;13(6):532-8.
• 87 Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep. 1995 Sep;18(7):598-603.
• 88 Rogers NL, Dinges DF, Kennaway DJ, Dawson D. Potential action of melatonin in insomnia. Sleep. 2003 Dec;26(8):1058-9.
• 89 Bujatti M, Biederer P. Serotonin, noradrenaline, dopamine metabolites in transcendental meditation-technique. J Neural Transm. 1976;39(3):257-67.
• 90 Liou CH, Hsieh CW, Hsieh CH, Chen JH, Wang CH, Lee SC. Studies of Chinese original quiet sitting by using functional magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5317-9.
• 91 Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett. 2002;23(Suppl 1):S17-S9.
• 92 Elias AN, Wilson AF. Serum hormonal concentrations following transcendental meditation--potential role of gamma aminobutyric acid. Med Hypotheses. 1995 Apr;44(4):287-91.
• 93 Guglietti CL, Daskalakis ZJ, Radhu N, Fitzgerald PB, Ritvo P. Meditation-related increases in GABAB modulated cortical inhibition. Brain Stimul. 2013 May;6(3):397-402.
• 94 Streeter CC, Jensen JE, Perlmutter RM, Cabral HJ, Tian H, Terhune DB, et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med. 2007 May;13(4):419-26.
• 95 MacLean CR, Walton KG, Wenneberg SR, Levitsky DK, Mandarino JP, Waziri R, et al. Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology. 1997 May;22(4):277-95.
• 96 Cooper R, Joffe B, Lamprey J, Botha A, Shires R, Baker S, et al. Hormonal and biochemical responses to transcendental meditation. Postgrad Med J. 1985 Apr;61(714):301-4.